Skip to main content

Table 1 Patients and disease characteristics

From: Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma

Characteristics Number of patients
Median age : years (range) 60 (51–66)
Gender  
- Male 5
- Female 1
Performans Status (PS)  
- 0 6
- >0 0
Disease stage  
- ≤2 0
- >3 6
Number of previous chemotherapies  
- 1 1
- 2 3
- 3 2
Disease status at transplantation  
- Complete response 3
- Partial response 3
PET-CT before transplantation  
- Negative 3
- Positive 3
Median time between diagnosis or relapse and ASCT (months) (range) 8.5 (7–12)